BRCA1 and BRCA2 pathogenic variants were identified in 12.6% (97/768) of breast cancer patients, whereas, 2.5% (19/768) of the individuals carried a variant in another high risk gene and 9.7% (74/768) in a moderate/low penetrance gene (Fig. 6). Here, BRCA1 is linked to breast carcinoma.